Laura Badjalimbe
Nurse Practitioner · Leawood, KSNPI 1336527134
Payments from drug & device makers
Across 186 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$656
- Lilly USA, LLC$547
- AstraZeneca$430
- Novo Nordisk$291
- Boehringer Ingelheim$173
- Amgen$132
- plus $889 from 27 others
What the payments were for
- Food & beverage$3,117100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $656 |
| Lilly USA, LLC | 31 | $547 |
| AstraZeneca | 25 | $430 |
| Novo Nordisk | 17 | $291 |
| Boehringer Ingelheim | 11 | $173 |
| Amgen | 7 | $132 |
| Nestle Healthcare Nutrition Inc. | 5 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $88 |
| Sanofi | 3 | $79 |
| Jazz Pharmaceuticals Inc. | 3 | $56 |
| Novartis | 3 | $53 |
| Eisai Inc. | 2 | $47 |
| Harmony Biosciences LLC | 2 | $42 |
| Boston Scientific | 2 | $41 |
| Viatris Specialty LLC | 2 | $31 |
| Amarin Pharma, Inc. | 2 | $31 |
| Abbott | 2 | $31 |
| GSK | 2 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Johnson & Johnson | 2 | $26 |
| Merck | 2 | $26 |
| Genentech USA, Inc. | 1 | $21 |
| Gilead | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Bayer | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Pfizer | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Cequr Corporation | 1 | $11 |
How this compares
$3,117 in reported general payments places this provider in the 90th percentile of 1,326 nurse practitioner providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 55 | $51,162 |
| OzempicSemaglutide | 31 | $41,654 |
| XareltoRivaroxaban | 21 | $18,530 |
| TradjentaLinagliptin | 21 | $17,521 |
| Breo ElliptaFluticasone/Vilanterol | 23 | $15,064 |
| Tresiba Flextouch U-100Insulin Degludec | 32 | $13,626 |
| LinzessLinaclotide | 18 | $9,977 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $9,680 |
| TrintellixVortioxetine Hydrobromide | 18 | $9,059 |
| GemtesaVibegron | 15 | $7,286 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 48 | $6,882 |
| MyrbetriqMirabegron | 12 | $5,510 |
| Levemir FlexpenInsulin Detemir | 13 | $3,245 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,019 |
| Pregabalin | 38 | $2,855 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $173 | $68,68376 claims |
| Novo NordiskOzempic | $291 | $41,65431 claims |
| Johnson & JohnsonXarelto | $26 | $18,53021 claims |
| GSKBreo Ellipta, Incruse Ellipta | $29 | $18,08234 claims |
| AbbVieLinzess | $656 | $9,97718 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $88 | $9,05918 claims |
| AstraZenecaSymbicort | $430 | $2,63513 claims |
| Lilly USA, LLCHumalog | $547 | $1,55112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,326 nurse practitioner providers in Kansas.
Other nurse practitioner in Leawood
- Gary GrafTopeka$726K
- Sarah FitzmauriceKansas City$247K
- Anna ShortRoeland Park$215K
- Shannon GreggTopeka$140K
- Morteza RabiiOverland Park$88K
- Constance JacobWichita$65K
- Michelle KirkHutchinson$58K
- Catherine PowellWichita$50K
- Lori RanalloWestwood$48K
- Kristyn MilburnPleasanton$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.